Mar 03, 2017 11:00am EST CohBar, Inc. to Announce Fourth Quarter 2016 Financial Results and Host Conference Call for Shareholders on March 22, 2017
Feb 21, 2017 8:30am EST CohBar, Inc. Announces Positive Results from Preclinical NASH Study of its Lead Drug Candidates
Feb 09, 2017 8:30am EST CohBar, Inc.’s CEO Simon Allen to Present at the 2017 BIO CEO & Investor Conference in New York
Jan 11, 2017 9:44am EST CohBar, Inc. Announces Expiration of Warrants and Reports Aggregate Proceeds from Warrant Exercises
Jan 10, 2017 8:06pm EST CohBar, Inc.’s CEO Simon Allen to Present at the 9th Annual Biotech Showcase in San Francisco
Dec 06, 2016 9:00am EST CohBar, Inc. Continues Exploration of Mitochondrial Genome and Expansion of Its IP Portfolio with Filing of 29 New Provisional Patents